Does APALUTAMIDE Cause Therapy cessation? 151 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Therapy cessation have been filed in association with APALUTAMIDE (ERLEADA). This represents 1.6% of all adverse event reports for APALUTAMIDE.
151
Reports of Therapy cessation with APALUTAMIDE
1.6%
of all APALUTAMIDE reports
4
Deaths
16
Hospitalizations
How Dangerous Is Therapy cessation From APALUTAMIDE?
Of the 151 reports, 4 (2.6%) resulted in death, 16 (10.6%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APALUTAMIDE. However, 151 reports have been filed with the FAERS database.
What Other Side Effects Does APALUTAMIDE Cause?
Rash (1,117)
Death (1,008)
Fatigue (824)
Hot flush (532)
Product dose omission issue (384)
Diarrhoea (317)
Asthenia (303)
Dizziness (294)
Fall (268)
Off label use (257)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which APALUTAMIDE Alternatives Have Lower Therapy cessation Risk?
APALUTAMIDE vs APATINIB
APALUTAMIDE vs APIDRA
APALUTAMIDE vs APIDRA SOLOSTAR
APALUTAMIDE vs APIXABAN
APALUTAMIDE vs APLISOL DIAGNOSTIC ANTIGEN